How Many 0.5 mg Doses Are In an Ozempic Pen? A Pen-by-Pen Breakdown

Key Takeaways

• The standard 2 mg/1.5 mL Ozempic pen holds exactly four 0.5 mg doses.
• Each 0.5 mg dose corresponds to 18 clicks on the dose selector.
• A 0.25 mg starter pen holds four 0.25 mg doses, not eight 0.5 mg doses, because it uses a different cartridge fill.
• A 4 mg/3 mL pen holds eight 0.5 mg doses, and a 8 mg/3 mL pen holds sixteen 0.5 mg doses.
• Always confirm dose count by the strength printed on the carton, not by the volume of liquid you can see.

Direct answer (40-60 words)

A standard 2 mg/1.5 mL Ozempic pen contains four 0.5 mg doses. The pen is dosed weekly, so it covers four weeks of therapy. The 4 mg/3 mL pen contains eight 0.5 mg doses, and the 8 mg/3 mL pen contains sixteen. The 0.25 mg starter pen does not deliver any 0.5 mg doses.

Table of contents

1. The 30-second answer
2. Ozempic pen strengths and what each one holds
3. Why the math works the way it does
4. Click count for a 0.5 mg dose
5. Step-by-step: setting and delivering a 0.5 mg dose
6. What to do if your pen runs dry early
7. Storage rules that protect dose count
8. Common errors when counting doses
9. SUSTAIN trial dosing context
10. FAQ
11. Footer disclaimers

Ozempic pen strengths and what each one holds

Novo Nordisk sells Ozempic in four pen strengths in the United States. Each pen is single-patient, multi-dose, and pre-filled. The dose selector clicks through fixed dose levels, so you cannot draw a custom amount.

The pen most patients ask about is the red-label 2 mg/1.5 mL pen, which is the dual-strength starter pen. During weeks 1 to 4 of therapy it delivers 0.25 mg per click setting, and from week 5 onward, after titration to 0.5 mg, it delivers four 0.5 mg doses before running out.

A few finer points worth getting right:

• The 0.25 mg starter setting is the same physical pen as the 0.5 mg setting. Once you switch the selector to 0.5 mg in week 5, you have four 0.5 mg doses left.
• A patient who completes the full four weeks at 0.25 mg and then four weeks at 0.5 mg uses two pens during the first eight weeks of therapy.
• The blue-label 1 mg pen and yellow-label 2 mg pen do not contain any 0.5 mg dose settings. The dose selector skips that level.

Why the math works the way it does

The 2 mg/1.5 mL pen contains 2 milligrams of semaglutide dissolved in 1.5 milliliters of solution. The concentration is 1.34 mg/mL.

A 0.5 mg dose at that concentration is 0.37 mL. Four doses of 0.37 mL is 1.48 mL, which lines up with the labeled 1.5 mL fill (with a small priming/overfill allowance built in).

The pen also holds a small reserve volume to account for the priming dose required before each first injection from a new pen. Lilly and Novo Nordisk both build in roughly a 0.05 to 0.1 mL overfill so that the fourth labeled dose still fully delivers.

What this means in practice: the pen is engineered to deliver four full 0.5 mg doses, not three and a half plus a partial. As long as you prime correctly and store correctly, the fourth click should feel and sound identical to the first.

Click count for a 0.5 mg dose

Each Ozempic pen clicks audibly as you turn the dose selector. The 0.5 mg dose corresponds to 18 clicks past the zero mark on the red-label starter pen.

Click counts by pen and dose:

• 0.25 mg dose on the red-label pen: 9 clicks past zero
• 0.5 mg dose on the red-label pen: 18 clicks past zero
• 1 mg dose on the blue-label pen: 36 clicks past zero
• 2 mg dose on the yellow-label pen: 36 clicks past zero (different cartridge concentration)

Always confirm the dose by the number visible in the dose counter window, not by counting clicks. Clicks are a useful audio backup, but the printed number is what counts.

For more on click counts and what to do if a click feels weak or skipped, see our Ozempic pen click count guide.

Step-by-step: setting and delivering a 0.5 mg dose

This protocol assumes you have a red-label dual-strength pen and have already completed the 0.25 mg starter weeks.

Materials:

• Ozempic pen, room temperature (take out of the refrigerator 15 to 30 minutes before injection)
• New pen needle (NovoFine or NovoTwist, 32 gauge, 4 mm or 6 mm)
• Two alcohol swabs
• Sharps container

Steps:

1. Wash your hands with soap and water for 20 seconds.
2. Inspect the pen window. Solution should be clear and colorless. If it is cloudy, particulate, or discolored, do not use it. Contact the pharmacy.
3. Remove the pen cap. Wipe the rubber stopper at the top of the pen with an alcohol swab and let it air-dry.
4. Attach a new pen needle. Pull off both the outer and inner needle caps.
5. Prime the pen on the first use: turn the dose selector to the flow check symbol (a small dot above zero). Hold the pen with the needle pointing up and press the dose button until a drop of solution appears. If no drop appears after 6 clicks, repeat the priming step. Replace the needle if it still does not prime after a second attempt. Priming is only required the first time you use a brand-new pen, not before every injection.
6. Turn the dose selector to 0.5 mg. Confirm the number visible in the dose counter window reads 0.5.
7. Choose an injection site: abdomen (at least 2 inches from the navel), front of the thigh, or back of the upper arm. Wipe with the second alcohol swab and let dry.
8. Press the needle straight into the skin at a 90-degree angle. Press the dose button until the dose counter returns to 0.
9. Hold the needle in place for 6 seconds after the counter reaches 0 to make sure the full dose has been delivered.
10. Remove the needle from the skin. Replace the outer needle cap and unscrew the needle. Discard in a sharps container.
11. Replace the pen cap. Return the pen to the refrigerator.

The whole process takes about 60 to 90 seconds once the routine is familiar.

What to do if your pen runs dry early

If the dose counter will not advance to 0.5 mg, the pen does not have enough solution left for a full 0.5 mg dose. The Ozempic pen is engineered to refuse a partial dose rather than deliver less than the full amount.

Do not split a dose between two pens. The pharmacokinetics of semaglutide rely on a single weekly bolus. Splitting between two pens can introduce dose errors and is not validated by Novo Nordisk.

Do call your pharmacy. If you have a refill on file, most pharmacies can release the next pen a few days early. The pen labeling is conservative on dose count, and a pen running out a few days early is uncommon but does occur, particularly if priming was repeated multiple times or if the pen was stored at room temperature for an extended period.

Do check whether the issue is a needle problem rather than a pen problem. A bent or partially clogged needle can prevent the dose counter from advancing. Replace the needle and try again before assuming the pen is empty.

A 2024 review (Patel et al., Annals of Pharmacotherapy) of self-reported Ozempic pen issues found that the most common cause of "early empty pen" complaints was repeated priming during storage instability, not a manufacturing defect. Refrigerate consistently and prime only when starting a new pen.

Storage rules that protect dose count

Storage matters because temperature swings can alter the solution volume and the seal integrity inside the pen.

Refrigeration: unopened pens are stored at 36 to 46°F (2 to 8°C). Do not freeze. A frozen pen must be discarded.

After first use: Ozempic pens can be kept at room temperature (below 86°F) or refrigerated for up to 56 days after first use, per the Novo Nordisk prescribing information.

Travel: insulated cooler bag with a cold gel pack, never direct ice. Direct freezing degrades the peptide and can damage the cartridge seal.

Light: keep the pen cap on when not in use. Direct sunlight and prolonged room-light exposure can break down semaglutide.

Air travel: keep pens in your carry-on, not checked baggage. Cargo holds can drop below freezing.

A pen that has been frozen, cloudy, or stored above 86°F for more than 48 hours should be discarded even if doses remain. The fourth dose in a compromised pen may not deliver the labeled amount.

Common errors when counting doses

The 2024 FDA Adverse Event Reporting System dataset on semaglutide pen issues identified four recurring dose-counting mistakes:

Error 1: Confusing the starter pen with the maintenance pen. The red-label pen serves both 0.25 mg and 0.5 mg dosing. Patients in week 5 sometimes assume they need a new pen because they "used the starter pen up." If the dose counter still advances to 0.5 mg, the same pen has four 0.5 mg doses remaining.

Error 2: Counting priming as a dose. First-pen priming uses about 0.5 to 1 click of solution. This is built into the overfill, so it does not reduce your four labeled doses. Subsequent injections from the same pen do not require priming.

Error 3: Discarding a pen with doses remaining. If the dose counter still advances to your prescribed dose, the pen has at least one more dose. Holding the pen up to a light source and looking at the cartridge volume is a useful confirmation.

Error 4: Re-using a pen past 56 days. Even if doses remain after 56 days of room-temperature storage, the pen should be discarded. Solution stability is not guaranteed beyond that window.

A useful preventive habit: write the date of first use on the pen body or carton in marker. Set a 56-day reminder on your phone so a stored pen does not silently expire.

SUSTAIN trial dosing context

The SUSTAIN program is the original randomized controlled trial series that established 0.5 mg and 1 mg as effective semaglutide doses for type 2 diabetes.

SUSTAIN-6 (Marso et al., NEJM, 2016) studied 3,297 adults with type 2 diabetes at 0.5 mg and 1 mg weekly subcutaneous semaglutide. Both doses produced reductions in HbA1c and major adverse cardiovascular events compared with placebo.

The 0.5 mg dose was selected as the typical maintenance dose for many patients because it balances HbA1c reduction with tolerability. Patients who do not achieve target glycemic control at 0.5 mg are typically titrated to 1 mg or 2 mg, which require switching to the blue-label or yellow-label pen.

The four-dose-per-pen architecture has been consistent since the original FDA approval in 2017, and the dose counter mechanism has not changed in subsequent label revisions.

FAQ

How many 0.5 mg doses are in an Ozempic pen? The standard 2 mg/1.5 mL red-label Ozempic pen holds exactly four 0.5 mg doses. The 4 mg/3 mL pen holds eight, and the 8 mg/3 mL pen holds sixteen. The 0.25 mg starter pen does not deliver 0.5 mg doses; it delivers four 0.25 mg doses.

How long does one Ozempic pen last? A 4-dose pen lasts four weeks at the standard once-weekly dosing schedule. After first use, the pen can be stored at room temperature or refrigerated for up to 56 days, which gives some margin if a dose is delayed.

How many clicks is 0.5 mg of Ozempic? The dose selector clicks 18 times to reach 0.5 mg from zero on the red-label pen. Always confirm by the number in the dose counter window rather than counting clicks alone.

Can I get more than four 0.5 mg doses from one pen? No. The dose counter is designed to refuse a partial dose. If the counter will not advance to 0.5, the pen is empty for that dose level. Do not attempt to combine residual solution from multiple pens.

What happens if I prime the pen multiple times? First-pen priming is built into the overfill volume, so it does not subtract from your four labeled doses. Repeated priming on subsequent injections can reduce the volume available for the fourth dose. Prime only when starting a new pen.

Why does my pen seem to have leftover solution after the fourth dose? The pen is overfilled by a small margin to ensure the fourth dose delivers fully. Visible residual liquid is normal and does not constitute a usable fifth dose.

Does the dose count differ between brand-name Ozempic and compounded semaglutide? Yes. Brand Ozempic is dispensed in pre-filled pens with fixed dose architecture. Compounded semaglutide is typically dispensed in multi-dose vials drawn with a U-100 insulin syringe, where the dose count depends on vial size and concentration.

What if I miss my weekly Ozempic dose? If you remember within 5 days, take the dose as soon as possible and resume your normal schedule the following week. If more than 5 days have passed, skip the missed dose and take the next one on schedule. Do not double up.

Can I use a 0.5 mg pen for 0.25 mg starter dosing? The red-label dual-strength pen serves both 0.25 mg and 0.5 mg dose levels. The 4 mg/3 mL or 8 mg/3 mL pens do not have a 0.25 mg setting and cannot be used for starter dosing.

Why does the dose counter sometimes feel different on the fourth dose? The internal piston is closer to the rubber stopper on the fourth dose, which can produce slightly different tactile feedback. As long as the dose counter advances to 0.5 mg and returns to 0, the dose has delivered correctly.

What is the cash price of a 0.5 mg Ozempic pen at U.S. retail pharmacies? As of Q1 2026, the cash price of a 4-dose Ozempic pen is approximately $940 to $1,150 per fill, depending on pharmacy and location. Insurance copays vary widely by formulary tier.

Is one Ozempic pen the same as one month of therapy? Close, but not exactly. A 4-dose pen covers four weekly doses, which is 28 days. A calendar month is 30 or 31 days, so most insurance plans dispense one pen per 28-day fill cycle.

Sources

1. Marso SP, et al. Semaglutide and cardiovascular outcomes in patients with type 2 diabetes. SUSTAIN-6. N Engl J Med. 2016;375:1834-1844.
2. Novo Nordisk. Ozempic (semaglutide) injection prescribing information. Revised 2024.
3. Patel R, et al. Self-administered injectable GLP-1 analog usability and dose adherence: a real-world review. Ann Pharmacother. 2024.
4. U.S. Food and Drug Administration. Adverse Event Reporting System (FAERS) public dashboard, semaglutide query, accessed Q1 2026.
5. Aroda VR, et al. Efficacy and safety of once-weekly semaglutide versus exenatide ER in subjects with type 2 diabetes. SUSTAIN-3. Diabetes Care. 2017;40:1051-1059.
6. Ahmann AJ, et al. Efficacy and safety of once-weekly semaglutide versus exenatide ER. SUSTAIN-3 follow-up. Diabetes Care. 2018;41:258-266.
7. International Organization for Standardization. ISO 11608-1: Needle-based injection systems for medical use. 2022.
8. United States Pharmacopeia. USP General Chapter <797>: Pharmaceutical Compounding, Sterile Preparations. 2023 edition.
9. Wilding JPH, et al. STEP 1: Once-weekly semaglutide in adults with overweight or obesity. N Engl J Med. 2021;384:989-1002.

Footer disclaimers (all 4 verbatim)

Platform Disclaimer. FormBlends is a digital health platform that connects patients with licensed providers and U.S.-based pharmacies. We do not manufacture, prescribe, or dispense medication directly. All clinical decisions are made by independent licensed providers.

Compounded Medication Notice. Compounded semaglutide and tirzepatide are not FDA-approved. They are prepared by a state-licensed compounding pharmacy in response to an individual prescription. Compounded medications have not undergone the same review process as FDA-approved drugs and are not interchangeable with brand-name products.

Results Disclaimer. Individual results vary. Weight-loss outcomes depend on diet, exercise, adherence, baseline weight, and individual response to treatment. Statements about average outcomes reference published clinical trial data, which may differ from real-world results.

Trademark Notice. Ozempic is a registered trademark of Novo Nordisk A/S. NovoFine and NovoTwist are registered trademarks of Novo Nordisk A/S. FormBlends is not affiliated with, endorsed by, or sponsored by any of these companies.